2026-04-10T19:27:00+01:00
References and support materials for ”Accelerating consistent, stable cell line development with targeted integration”
Zalma V, et al. CHO Cells For Virus-Like Particle And Subunit Vaccine Manufacturing. Vaccine. 2024;42: 2530-2542.
Tihanyi B, Nyitray L. Recent Advances In CHO Cell Line Development For Recombinant Protein Production. Drug Discovery Today: Technologies. 2020;38: 25-34.
WuXi Biologics Launches WuXia™4.0, Targeted Integration Cell Line Platform TrueSite TI™ to Accelerate Biologics Development with High Titer and Superior Stability. [Internet] WuXI Biologics. 2025. Available from: https://www.wuxibiologics.com/press-release/wuxi-biologics-launches-wuxia4-targeted-integration-cell-line-platform-truesite-ti-accelerate-biologics-development-with-high-titer-and-superior-stability/
McGovern ĀT, Salisbury C, Nyberg G. The Pandemic and Resilience for the Future: AccBio 2021. Biotechnol. Prog. 2022;38:e3207.
2026-04-14T12:31:00
Sponsored by Yokogawa Europe B.V
2026-08-25T08:09:00
Sponsored by LabVantage
2026-10-07T14:00:00
Sponsored by Thermo Fisher Scientific
2026-03-18T15:00:00
Sponsored by Sartorius
2026-06-30T10:37:00
Sponsored by Bruker (SciY), European Pharmaceutical Review
2026-11-19T15:00:00
Sponsored by Bio-Rad Laboratories Inc.
No comments yet